Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Indivior Pharmaceuticals, Inc. INDV

Full chart Compare
Set alert

Price alert · INDV

All alert types
36.28 USD +0.91 (+2.57%)

At closeNov 2, 2026, 5:43 PM EST

36.30 +0.02 +0.06%

After hours · Nov 2, 5:43 PM ET

35.32 Day range 37.01
27.68 52-week range 42.81
YTD
+1.11%
1 year
+23.53%

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 49.50 +36.4% upside
Target (low)
45.00
Target (mean)
49.50
Target (high)
53.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy3
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 4
  • 1 month ago 4

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

INDV analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter1.221.22 – 1.220.82+48.8%337.90M-5.6%1
Next quarter0.93950.859 – 1.020.96-2.1%328.00M+3.5%2
Current year4.424.36 – 4.472.50+76.6%1.33B+7.5%2
Next year4.513.89 – 4.894.42+2.1%1.40B+5.1%3

Upgrades and downgrades

The latest rating changes

INDV analyst upgrades and downgrades
DateFirmActionFromTo
Oct 28, 2026BarclaysMaintainedOverweightOverweight
Aug 5, 2026BarclaysMaintainedOverweightOverweight
Jun 18, 2026BarclaysInitiated—Overweight
Jan 12, 2026HC Wainwright & Co.MaintainedBuyBuy
Oct 31, 2025Piper SandlerReiteratedOverweightOverweight
Oct 30, 2025HC Wainwright & Co.MaintainedBuyBuy
Aug 27, 2025Craig-HallumMaintainedBuyBuy
Aug 6, 2025HC Wainwright & Co.Initiated—Buy
Jun 30, 2025Craig-HallumMaintainedBuyBuy
Mar 6, 2025Piper SandlerMaintainedOverweightOverweight
Oct 25, 2024Piper SandlerReiteratedOverweightOverweight
Oct 11, 2024Craig-HallumMaintainedBuyBuy
Oct 11, 2024Piper SandlerReiteratedOverweightOverweight
Sep 13, 2024Piper SandlerReiteratedOverweightOverweight
Jul 23, 2024Piper SandlerInitiated—Overweight
Jul 10, 2024Craig-HallumMaintainedBuyBuy
Apr 3, 2024Craig-HallumInitiated—Buy